In the article on antibody-endostatin fusion protein in the May 2005 issue (1), the last name of author Dr. Hovav Nechushtan was spelled incorrectly.

1
Cho H-M, Rosenblatt JD, Kang Y-S, et al. Enhance inhibition of murine tumor and human breast tumor xenografts using targeted delivery of an antibody-endostatin fusion protein.
Mol Cancer Ther
 
2005
;
4
:
956
–67.
View Original Article
American Association for Cancer Research
2005